Staar Looking To AquaFlow, ICL To Drive Growth; Firm Cutting Workforce 25%
This article was originally published in The Gray Sheet
Executive Summary
Staar Surgical's revised growth strategy hinges on cutting costs in its mature intraocular lens (IOL) business and sharpening its focus on the high growth, high margin glaucoma and refractive surgery markets, the firm announced Aug. 1.